Literature DB >> 23743690

Author's Reply to Kotlinska-Lemieszek: "Should Midazolam Drug-Drug Interactions Be of Concern to Palliative Care Physicians?".

Sebastian Frechen1, Jan Gaertner2.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23743690     DOI： 10.1007/s40264-013-0067-1

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  18 in total

1.  In vitro and in vivo glucuronidation of midazolam in humans.

Authors:  Ruth Hyland; Toby Osborne; Anthony Payne; Sarah Kempshall; Y Raj Logan; Khaled Ezzeddine; Barry Jones
Journal:  Br J Clin Pharmacol       Date:  2009-04       Impact factor: 4.335

2.  Should Midazolam Drug-Drug Interactions be of Concern to Palliative Care Physicians?

Authors:  Aleksandra Kotlinska-Lemieszek
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

3.  A semiphysiological population pharmacokinetic model for dynamic inhibition of liver and gut wall cytochrome P450 3A by voriconazole.

Authors:  Sebastian Frechen; Lisa Junge; Teijo I Saari; Ahmed Abbas Suleiman; Dennis Rokitta; Pertti J Neuvonen; Klaus T Olkkola; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2013-09       Impact factor: 6.447

4.  Drug interactions in palliative care--it's more than cytochrome P450.

Authors:  Jan Gaertner; Klaus Ruberg; Grit Schlesiger; Sebastian Frechen; Raymond Voltz
Journal:  Palliat Med       Date:  2011-07-07       Impact factor: 4.762

5.  Drug interactions in dying patients: a retrospective analysis of hospice inpatients in Germany.

Authors:  Sebastian Frechen; Anna Zoeller; Klaus Ruberg; Raymond Voltz; Jan Gaertner
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

Review 6.  Cytochrome P-450 3A4: regulation and role in drug metabolism.

Authors:  F P Guengerich
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

7.  Pharmacotherapy at the end-of-life.

Authors:  Denis O'Mahony; Marie N O'Connor
Journal:  Age Ageing       Date:  2011-05-28       Impact factor: 10.668

Review 8.  Evaluation of the toxicological relevance of CYP3A4 induction.

Authors:  Nick J Plant; G Gordon Gibson
Journal:  Curr Opin Drug Discov Devel       Date:  2003-01

9.  Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite.

Authors:  Xin Zhang; Sara K Quinney; J Christopher Gorski; David R Jones; Stephen D Hall
Journal:  Drug Metab Dispos       Date:  2009-05-06       Impact factor: 3.922

10.  Absolute bioavailability of midazolam after subcutaneous administration to healthy volunteers.

Authors:  M Pecking; F Montestruc; P Marquet; E Wodey; M-C Homery; P Dostert
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.